Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Allergy-associated biomarkers in early life identified by Omics techniques

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The prevalence and severity of allergic diseases have increased over the last 30 years. Understanding the mechanisms responsible for these diseases is a major challenge in current allergology, as it is crucial for the transition towards precision medicine, which encompasses predictive, preventive, and personalized strategies. The urge to identify predictive biomarkers of allergy at early stages of life is crucial, especially in the context of major allergic diseases such as food allergy and atopic dermatitis. Identifying these biomarkers could enhance our understanding of the immature immune responses, improve allergy handling at early ages and pave the way for preventive and therapeutic approaches. This minireview aims to explore the relevance of three biomarker categories (proteome, microbiome, and metabolome) in early life. First, levels of some proteins emerge as potential indicators of mucosal health and metabolic status in certain allergic diseases. Second, bacterial taxonomy provides insight into the composition of the microbiota through high-throughput sequencing methods. Finally, metabolites, representing the end products of bacterial and host metabolic activity, serve as early indicators of changes in microbiota and host metabolism. This information could help to develop an extensive identification of biomarkers in AD and FA and their potential in translational personalized medicine in early life.

          Related collections

          Most cited references172

          • Record: found
          • Abstract: found
          • Article: not found

          The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.

          Regulatory T cells (Tregs) that express the transcription factor Foxp3 are critical for regulating intestinal inflammation. Candidate microbe approaches have identified bacterial species and strain-specific molecules that can affect intestinal immune responses, including species that modulate Treg responses. Because neither all humans nor mice harbor the same bacterial strains, we posited that more prevalent factors exist that regulate the number and function of colonic Tregs. We determined that short-chain fatty acids, gut microbiota-derived bacterial fermentation products, regulate the size and function of the colonic Treg pool and protect against colitis in a Ffar2-dependent manner in mice. Our study reveals that a class of abundant microbial metabolites underlies adaptive immune microbiota coadaptation and promotes colonic homeostasis and health.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

            Upon delivery, the neonate is exposed for the first time to a wide array of microbes from a variety of sources, including maternal bacteria. Although prior studies have suggested that delivery mode shapes the microbiota's establishment and, subsequently, its role in child health, most researchers have focused on specific bacterial taxa or on a single body habitat, the gut. Thus, the initiation stage of human microbiome development remains obscure. The goal of the present study was to obtain a community-wide perspective on the influence of delivery mode and body habitat on the neonate's first microbiota. We used multiplexed 16S rRNA gene pyrosequencing to characterize bacterial communities from mothers and their newborn babies, four born vaginally and six born via Cesarean section. Mothers' skin, oral mucosa, and vagina were sampled 1 h before delivery, and neonates' skin, oral mucosa, and nasopharyngeal aspirate were sampled <5 min, and meconium <24 h, after delivery. We found that in direct contrast to the highly differentiated communities of their mothers, neonates harbored bacterial communities that were undifferentiated across multiple body habitats, regardless of delivery mode. Our results also show that vaginally delivered infants acquired bacterial communities resembling their own mother's vaginal microbiota, dominated by Lactobacillus, Prevotella, or Sneathia spp., and C-section infants harbored bacterial communities similar to those found on the skin surface, dominated by Staphylococcus, Corynebacterium, and Propionibacterium spp. These findings establish an important baseline for studies tracking the human microbiome's successional development in different body habitats following different delivery modes, and their associated effects on infant health.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The gut microbiota shapes intestinal immune responses during health and disease.

              Immunological dysregulation is the cause of many non-infectious human diseases such as autoimmunity, allergy and cancer. The gastrointestinal tract is the primary site of interaction between the host immune system and microorganisms, both symbiotic and pathogenic. In this Review we discuss findings indicating that developmental aspects of the adaptive immune system are influenced by bacterial colonization of the gut. We also highlight the molecular pathways that mediate host-symbiont interactions that regulate proper immune function. Finally, we present recent evidence to support that disturbances in the bacterial microbiota result in dysregulation of adaptive immune cells, and this may underlie disorders such as inflammatory bowel disease. This raises the possibility that the mammalian immune system, which seems to be designed to control microorganisms, is in fact controlled by microorganisms.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/2658523/Role: Role: Role: Role: Role: Role: Role:
                Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/660747/overviewRole: Role: Role: Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/525386/overviewRole: Role: Role: Role: Role: Role: Role: Role: Role:
                Journal
                Front Allergy
                Front Allergy
                Front. Allergy
                Frontiers in Allergy
                Frontiers Media S.A.
                2673-6101
                2673-6101
                23 February 2024
                2024
                : 5
                : 1359142
                Affiliations
                [ 1 ]Institute of Applied Molecular Medicine Nemesio Díez (IMMA), Department of Basic Medical Sciences, Facultad de Medicina. Universidad San Pablo-CEU, CEU Universities , Madrid, Spain
                [ 2 ]Department of Allergy, H. Infantil Universitario Niño Jesús, FibHNJ, ARADyAL- RETICs Instituto de Salud Carlos III, IIS-P , Madrid, Spain
                [ 3 ]Department of Dermatology, University Hospital Duesseldorf, Heinrich-Heine University , Duesseldorf, Germany
                Author notes

                Edited by: Elina Toskala, Thomas Jefferson University, United States

                Reviewed by: Anna Maria Ehlers, Utrecht University, Netherlands

                [* ] Correspondence: Marina Pérez-Gordo marina.perezgordo@ 123456ceu.es
                [ † ]

                These authors have contributed equally to this work

                [ ‡ ]

                ORCID Elisa Zubeldia-Varela orcid.org/0000-0002-3030-6313 María Dolores Ibáñez-Sandín orcid.org/0000-0001-8291-5121 Cristina Gomez-Casado orcid.org/0000-0002-7707-6367 Marina Pérez-Gordo orcid.org/0000-0003-2003-4841

                Article
                10.3389/falgy.2024.1359142
                10920277
                38464396
                7abfa556-030e-47ad-b3d6-541aa07826eb
                © 2024 Zubeldia-Varela, Ibáñez-Sandín, Gomez-Casado and Pérez-Gordo.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 20 December 2023
                : 12 February 2024
                Page count
                Figures: 1, Tables: 1, Equations: 0, References: 172, Pages: 0, Words: 0
                Funding
                Funded by: ISCIII
                Award ID: PI20/01366
                Funded by: Ministerio de Ciencia, Innovación y Universidades
                Award ID: RTI2018-095166-B-I00
                Funded by: European Regional Development Fund “Investing in your future” for the thematic network and co-operative research centers ARADyAL
                Award ID: RD16/0006/0015, RD16/0006/0016
                Funded by: RICORS “Red de Enfermedades Inflamatorias (REI)”
                Award ID: RD21/0002/0008
                The author(s) declare financial support was received for the research, authorship, and/or publication of this article.
                This study was supported by the ISCIII (Project number PI20/01366), the Ministerio de Ciencia, Innovación y Universidades (RTI2018-095166-B-I00), and the European Regional Development Fund “Investing in your future” for the thematic network and co-operative research centers ARADyAL (RD16/0006/0015 and RD16/0006/0016), RICORS “Red de Enfermedades Inflamatorias (REI)” (RD21/0002/0008) and co-funded by the European program ERA HDHL – Nutrition & the Epigenome, Project Dietary Intervention in Food Allergy: Microbiome, Epigenetic and Metabolomic Interactions DIFAMEM.
                Categories
                Allergy
                Mini Review
                Custom metadata
                Mechanisms in Allergy

                atopy,atopic dermatitis,biomarkers,early life,food allergy,metabolome,microbiome,proteome

                Comments

                Comment on this article